The price of Novartis AG (NYSE: NVS) closed at 77.14 in the last session, down -0.52% from day before closing price of $77.54. In other words, the price has decreased by $-0.40 from its previous closing price. On the day, 3948727 shares were traded. NVS reached its highest trading level at $77.43 during the session, while it also had its lowest trading level at $76.26.

**Top 5 Cheap Stocks to Own Right Now
**

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

**
Sign up here to get your free report now. **.

Sponsored

### Ratios:

We take a closer look at NVS’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.41 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 34.53. For the most recent quarter (mrq), Quick Ratio is recorded 1.10 and its Current Ratio is at 1.40. In the meantime, Its Debt-to-Equity ratio is 0.49 whereas as Long-Term Debt/Eq ratio is at 0.38.

### Upgrades & Downgrades

### Valuation Measures:

As of this moment, Novartis’s Price-to-Earnings (P/E) ratio for their current fiscal year is 7.56, and their Forward P/E ratio for the next fiscal year is 11.55. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.82. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.52 while its Price-to-Book (P/B) ratio in mrq is 2.69.

### Stock Price History:

Over the past 52 weeks, NVS has reached a high of $94.26, while it has fallen to a 52-week low of $77.50. The 50-Day Moving Average of the stock is 83.57, while the 200-Day Moving Average is calculated to be 85.90.

### Shares Statistics:

According to the various share statistics, NVS traded on average about 2.11M shares per day over the past 3-months and 2.07M shares per day over the past 10 days. A total of 2.20B shares are outstanding, with a floating share count of 2.18B. Insiders hold about 9.30% of the company’s shares, while institutions hold 9.20% stake in the company. Shares short for NVS as of Jul 14, 2022 were 6.02M with a Short Ratio of 2.69, compared to 6.24M on Jun 14, 2022.

### Dividends & Splits

The forward annual dividend rate for NVS is 3.33, which was 3.40 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 4.38%, it implies a Forward Annual Dividend Yield of 3.87%. The stock’s 5-year Average Dividend Yield is 3.48. The current Payout Ratio is 31.10% for NVS, which recently paid a dividend on Mar 16, 2022 with an ex-dividend date of Mar 07, 2022. Stock splits for the company last occurred on Apr 08, 2019 when the company split stock in a 1116:1000 ratio.

### Earnings Estimates

The company has 4 analysts who recommend its stock at the moment. On average, analysts expect EPS of $1.55 for the current quarter, with a high estimate of $1.6 and a low estimate of $1.5, while EPS last year was $1.71. The consensus estimate for the next quarter is $1.47, with high estimates of $1.53 and low estimates of $1.42.

Analysts are recommending an EPS of between $6.42 and $5.89 for the fiscal current year, implying an average EPS of $6.11. EPS for the following year is $6.69, with 19 analysts recommending between $7.02 and $6.46.

### Revenue Estimates

According to 4 analysts, the current quarter’s revenue is expected to be $13.04B. It ranges from a high estimate of $13.36B to a low estimate of $12.71B. As of the current estimate, Novartis AG’s year-ago sales were $13.03B, an estimated increase of 0.10% from the year-ago figure. For the next quarter, 4 analysts are estimating revenue of $13.44B, an increase of 1.60% over than the figure of $0.10% in the same quarter last year. There is a high estimate of $13.62B for the next quarter, whereas the lowest estimate is $13.29B.

A total of 18 analysts have provided revenue estimates for NVS’s current fiscal year. The highest revenue estimate was $54.93B, while the lowest revenue estimate was $50.98B, resulting in an average revenue estimate of $52.5B. In the same quarter a year ago, actual revenue was $51.63B, up 1.70% from the average estimate. Based on 19 analysts’ estimates, the company’s revenue will be $54.01B in the next fiscal year. The high estimate is $56.77B and the low estimate is $51.6B. The average revenue growth estimate for next year is up 2.90% from the average revenue estimate for this year.